Soft tissue sarcoma, version 2.2018: Clinical practice guidelines in oncology

Margaret Von Mehren; R. Lor Randall; Robert S. Benjamin; Sarah Boles; Marilyn M. Bui; Kristen N. Ganjoo; Suzanne George; Ricardo J. Gonzalez; Martin J. Heslin; John M. Kane; Vicki Keedy; Edward Kim; Henry Koon; Joel Mayerson; Martin McCarter; Sean V. McGarry; Christian Meyer; Zachary S. Morris; Richard J. O'Donnell; Alberto S. Pappo; I. Benjamin Paz; Ivy A. Petersen; John D. Pfeifer; Richard F. Riedel; Bernice Ruo; Scott Schuetze; William D. Tap; Jeffrey D. Wayne; Mary Anne Bergman; Jillian L. Scavone

doi:10.6004/jnccn.2018.0025

Soft tissue sarcoma, version 2.2018: Clinical practice guidelines in oncology

Margaret Von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah Boles, Marilyn M. Bui, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane, Vicki Keedy, Edward Kim, Henry Koon, Joel Mayerson, Martin McCarter, Sean V. McGarry, Christian Meyer, Zachary S. Morris, Richard J. O'Donnell, Alberto S. PappoI. Benjamin Paz, Ivy A. Petersen, John D. Pfeifer, Richard F. Riedel, Bernice Ruo, Scott Schuetze, William D. Tap, Jeffrey D. Wayne, Mary Anne Bergman, Jillian L. Scavone

Surgery, Surgical Oncology Division

Research output: Contribution to journal › Review article › peer-review

387 Scopus citations

Abstract

Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intraabdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.

Original language	English (US)
Pages (from-to)	536-563
Number of pages	28
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	16
Issue number	5
DOIs	https://doi.org/10.6004/jnccn.2018.0025
State	Published - May 1 2018

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2018.0025

Cite this

Mehren, M. V., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Ganjoo, K. N., George, S., Gonzalez, R. J., Heslin, M. J., Kane, J. M., Keedy, V., Kim, E., Koon, H., Mayerson, J., McCarter, M., McGarry, S. V., Meyer, C., Morris, Z. S., O'Donnell, R. J., ... Scavone, J. L. (2018). Soft tissue sarcoma, version 2.2018: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 16(5), 536-563. https://doi.org/10.6004/jnccn.2018.0025

@article{5186c8a6fb7b43a2bd302946dafa4549,

title = "Soft tissue sarcoma, version 2.2018: Clinical practice guidelines in oncology",

abstract = "Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intraabdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.",

author = "Mehren, {Margaret Von} and Randall, {R. Lor} and Benjamin, {Robert S.} and Sarah Boles and Bui, {Marilyn M.} and Ganjoo, {Kristen N.} and Suzanne George and Gonzalez, {Ricardo J.} and Heslin, {Martin J.} and Kane, {John M.} and Vicki Keedy and Edward Kim and Henry Koon and Joel Mayerson and Martin McCarter and McGarry, {Sean V.} and Christian Meyer and Morris, {Zachary S.} and O'Donnell, {Richard J.} and Pappo, {Alberto S.} and Paz, {I. Benjamin} and Petersen, {Ivy A.} and Pfeifer, {John D.} and Riedel, {Richard F.} and Bernice Ruo and Scott Schuetze and Tap, {William D.} and Wayne, {Jeffrey D.} and Bergman, {Mary Anne} and Scavone, {Jillian L.}",

note = "Funding Information: Alan B. Slifka Foundation; Biomet, Inc.; International Society of Pediatric Oncology; Musculoskeletal Transplant Foundation; and Sarcoma Foundation of America Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2018",

month = may,

day = "1",

doi = "10.6004/jnccn.2018.0025",

language = "English (US)",

volume = "16",

pages = "536--563",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "5",

}

Mehren, MV, Randall, RL, Benjamin, RS, Boles, S, Bui, MM, Ganjoo, KN, George, S, Gonzalez, RJ, Heslin, MJ, Kane, JM, Keedy, V, Kim, E, Koon, H, Mayerson, J, McCarter, M, McGarry, SV, Meyer, C, Morris, ZS, O'Donnell, RJ, Pappo, AS, Paz, IB, Petersen, IA, Pfeifer, JD, Riedel, RF, Ruo, B, Schuetze, S, Tap, WD, Wayne, JD, Bergman, MA & Scavone, JL 2018, 'Soft tissue sarcoma, version 2.2018: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 5, pp. 536-563. https://doi.org/10.6004/jnccn.2018.0025

TY - JOUR

T1 - Soft tissue sarcoma, version 2.2018

T2 - Clinical practice guidelines in oncology

AU - Mehren, Margaret Von

AU - Randall, R. Lor

AU - Benjamin, Robert S.

AU - Boles, Sarah

AU - Bui, Marilyn M.

AU - Ganjoo, Kristen N.

AU - George, Suzanne

AU - Gonzalez, Ricardo J.

AU - Heslin, Martin J.

AU - Kane, John M.

AU - Keedy, Vicki

AU - Kim, Edward

AU - Koon, Henry

AU - Mayerson, Joel

AU - McCarter, Martin

AU - McGarry, Sean V.

AU - Meyer, Christian

AU - Morris, Zachary S.

AU - O'Donnell, Richard J.

AU - Pappo, Alberto S.

AU - Paz, I. Benjamin

AU - Petersen, Ivy A.

AU - Pfeifer, John D.

AU - Riedel, Richard F.

AU - Ruo, Bernice

AU - Schuetze, Scott

AU - Tap, William D.

AU - Wayne, Jeffrey D.

AU - Bergman, Mary Anne

AU - Scavone, Jillian L.

N1 - Funding Information: Alan B. Slifka Foundation; Biomet, Inc.; International Society of Pediatric Oncology; Musculoskeletal Transplant Foundation; and Sarcoma Foundation of America Publisher Copyright: © JNCCN-Journal of the National Comprehensive Cancer Network.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intraabdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.

AB - Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intraabdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.

UR - http://www.scopus.com/inward/record.url?scp=85046897802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046897802&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2018.0025

DO - 10.6004/jnccn.2018.0025

M3 - Review article

C2 - 29752328

AN - SCOPUS:85046897802

SN - 1540-1405

VL - 16

SP - 536

EP - 563

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 5

ER -

Soft tissue sarcoma, version 2.2018: Clinical practice guidelines in oncology

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this